NO881884D0 - Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.

Info

Publication number
NO881884D0
NO881884D0 NO881884A NO881884A NO881884D0 NO 881884 D0 NO881884 D0 NO 881884D0 NO 881884 A NO881884 A NO 881884A NO 881884 A NO881884 A NO 881884A NO 881884 D0 NO881884 D0 NO 881884D0
Authority
NO
Norway
Prior art keywords
procedure
preparation
therapeutic active
pyrrolidine derivatives
active pyrrolidine
Prior art date
Application number
NO881884A
Other languages
English (en)
Other versions
NO173330C (no
NO173330B (no
NO881884L (no
Inventor
Hiroyuki Setoi
Hideo Hirai
Hiroshi Marusawa
Akio Kuroda
Hirokazu Tanaka
Masashi Hashimoto
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878710352A external-priority patent/GB8710352D0/en
Priority claimed from GB878716438A external-priority patent/GB8716438D0/en
Priority claimed from GB878730027A external-priority patent/GB8730027D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO881884D0 publication Critical patent/NO881884D0/no
Publication of NO881884L publication Critical patent/NO881884L/no
Publication of NO173330B publication Critical patent/NO173330B/no
Publication of NO173330C publication Critical patent/NO173330C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO881884A 1987-05-01 1988-04-29 Anologifremgangsm}te for fremstilling av terapeutisk aktive pyrrolidin-derivater NO173330C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878710352A GB8710352D0 (en) 1987-05-01 1987-05-01 Pyrrolidine derivatives
GB878716438A GB8716438D0 (en) 1987-07-13 1987-07-13 Pyrrolidine derivatives
GB878730027A GB8730027D0 (en) 1987-12-23 1987-12-23 Pyrrolidine derivatives

Publications (4)

Publication Number Publication Date
NO881884D0 true NO881884D0 (no) 1988-04-29
NO881884L NO881884L (no) 1988-11-02
NO173330B NO173330B (no) 1993-08-23
NO173330C NO173330C (no) 1993-12-01

Family

ID=27263412

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881884A NO173330C (no) 1987-05-01 1988-04-29 Anologifremgangsm}te for fremstilling av terapeutisk aktive pyrrolidin-derivater

Country Status (18)

Country Link
US (1) US4916152A (no)
EP (1) EP0289911B1 (no)
JP (1) JPS63295553A (no)
KR (1) KR970005190B1 (no)
CN (1) CN1020899C (no)
AR (1) AR247879A1 (no)
AU (1) AU613360B2 (no)
CA (1) CA1329391C (no)
DE (1) DE3881755T2 (no)
DK (1) DK233888A (no)
ES (1) ES2054729T3 (no)
FI (1) FI88716C (no)
HU (1) HU208671B (no)
IE (1) IE62862B1 (no)
IL (1) IL86173A (no)
NO (1) NO173330C (no)
PH (1) PH24950A (no)
PT (1) PT87359B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130323A (en) * 1988-10-31 1992-07-14 Fujisawa Pharmaceutical Co., Ltd. Pyrrolidine derivatives
US5264453A (en) * 1988-10-31 1993-11-23 Fujisawa Pharmaceutical Co., Ltd. Pyrrolidine derivatives
FR2685325B1 (fr) * 1991-12-20 1994-02-04 Adir Cie Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2687146B1 (fr) * 1992-02-12 1994-04-01 Adir Cie Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
RU94046180A (ru) * 1992-07-02 1996-10-27 Фудзисава Фармасьютикал Ко. Способ получения производного пирролидина и его соли, исходный продукт и способ его получения
KR100671658B1 (ko) 2005-01-05 2007-01-19 삼성에스디아이 주식회사 마스크 프레임 및 이를 사용한 마스크 고정방법
CA3043911A1 (en) * 2007-12-04 2009-07-02 Arbutus Biopharma Corporation Targeting lipids
CN109912487B (zh) * 2019-03-25 2023-01-10 山东理工大学 一种合成1-对甲苯磺酰基-2-乙烯基-1氢-吡咯的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577440A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-amido-pyrrolidines
US4282243A (en) * 1972-04-03 1981-08-04 A. H. Robins Company, Inc. Optical isomers of 4-amino-N-(1-cyclohexyl-3-pyrrolidinyl)-N-methylbenzamide
US4210660A (en) * 1978-12-20 1980-07-01 Yamanouchi Pharmaceutical Co., Ltd. Benzamide derivatives
DE3165669D1 (en) * 1980-06-23 1984-09-27 Squibb & Sons Inc Azido, imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids having hypotensive activity
GB8509703D0 (en) * 1985-04-16 1985-05-22 Fujisawa Pharmaceutical Co Pyrrolidine derivatives
US4785119A (en) * 1985-10-11 1988-11-15 Tokyo Kasei Kogyo Co., Ltd. 3-aminopyrrolidine compound and process for preparation thereof
JPH07108898B2 (ja) * 1986-08-20 1995-11-22 大日本製薬株式会社 3−アミノピロリジン誘導体およびその塩の製造法
US5130323A (en) * 1988-10-31 1992-07-14 Fujisawa Pharmaceutical Co., Ltd. Pyrrolidine derivatives

Also Published As

Publication number Publication date
JPS63295553A (ja) 1988-12-01
IL86173A (en) 1992-02-16
CN1020899C (zh) 1993-05-26
PH24950A (en) 1990-12-26
FI882015A0 (fi) 1988-04-29
DE3881755T2 (de) 1993-10-21
NO173330C (no) 1993-12-01
HU208671B (en) 1993-12-28
HUT48579A (en) 1989-06-28
FI882015A (fi) 1988-11-02
AU613360B2 (en) 1991-08-01
AR247879A1 (es) 1995-04-28
DK233888D0 (da) 1988-04-28
NO173330B (no) 1993-08-23
DE3881755D1 (de) 1993-07-22
CN88102511A (zh) 1988-11-23
DK233888A (da) 1988-11-02
EP0289911B1 (en) 1993-06-16
FI88716C (fi) 1993-06-28
CA1329391C (en) 1994-05-10
NO881884L (no) 1988-11-02
EP0289911A3 (en) 1989-08-16
US4916152A (en) 1990-04-10
EP0289911A2 (en) 1988-11-09
KR970005190B1 (ko) 1997-04-14
AU1534888A (en) 1988-11-03
FI88716B (fi) 1993-03-15
PT87359A (pt) 1989-05-31
ES2054729T3 (es) 1994-08-16
KR880013889A (ko) 1988-12-22
JPH0546335B2 (no) 1993-07-13
IE881260L (en) 1988-11-01
IL86173A0 (en) 1988-11-15
PT87359B (pt) 1992-08-31
IE62862B1 (en) 1995-03-08

Similar Documents

Publication Publication Date Title
NO883974D0 (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO894630D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO871266D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO901684L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO883122L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO881762D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzazepinderivater.
NO880667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO884176D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater.
NO891723L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO884175L (no) Fremgangsmaate for fremstilling av terapeutiske aktive heterocykliske derivater.
NO881884L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
NO167739C (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive ginkolid-derivater.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO890724L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO883959L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO890519D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater.